Phase II study of oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma.
| Image |  |
|---|---|
| Description | scientific article published on 19 January 2018 |
| Author/s |
author: Corinne Haioun Anne-Ségolène Cottereau René-Olivier Casasnovas Eric Van Den Neste Thomas Gastinne Franck Morschhauser |
| Publication date | January 19, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |